At the core of BPA’s reproductive toxicity is its ability to augment the production of reactive oxygen species (ROS). ROS are chemically reactive molecules containing oxygen that, in excess, cause oxidative stress—a condition characterized by cellular damage caused by the oxidation of lipids, proteins, and DNA. Sperm cells, due to their high polyunsaturated fatty acid content and limited antioxidative defenses, are especially vulnerable to oxidative stress. Elevated ROS levels disrupt sperm membrane integrity and mitochondrial function, culminating in reduced sperm motility and viability, as well as DNA fragmentation which compromises fertilization potential.

Recognizing the imperative to counteract oxidative damage, researchers at Osaka Metropolitan University (OMU) have embarked on innovative research exploring antioxidant interventions targeting BPA-induced sperm toxicity. A promising avenue has emerged in the use of paraprobiotics—heat-inactivated bacterial cells that retain their immunomodulatory and bioactive properties without the risks associated with live bacteria. These paraprobiotics stimulate the gut-immune axis, a critical biological interface linking microbiota-derived signals to systemic oxidative stress and inflammation responses.

The OMU research team focused on a specific paraprobiotic derived from Enterococcus faecalis, designated FK-23, which has a well-established history of safe use in dietary supplements. Unlike conventional probiotics, FK-23 is heat-treated, ensuring that the bacteria cannot reproduce but still maintain surface structures capable of modulating immune functions beneficially. By administering FK-23, researchers hypothesized it would enhance the body’s antioxidative capacity and thus protect sperm from BPA-induced oxidative insults.

To evaluate the efficacy of FK-23 in preventing reproductive harm, the OMU team conducted a controlled experimental study using rodent models exposed to BPA. As anticipated, BPA exposure led to a significant decline in sperm motility and an increase in oxidative stress biomarkers, confirming the compound’s detrimental impact on male reproductive health. However, rats that concurrently received FK-23 supplementation demonstrated notable improvements in sperm motility and a reduction in biochemical markers of oxidative stress compared to those exposed to BPA alone.

The mechanisms underlying FK-23’s protective effects appear multifaceted but centrally involve the modulation of the gut-immune system axis. The paraprobiotic’s cell wall components interact with gut-associated lymphoid tissue, triggering anti-inflammatory signaling and upregulation of endogenous antioxidant enzymes. This systemic immunomodulation contributes to attenuating oxidative stress in distant tissues, including the testes, thereby preserving sperm function despite environmental toxicant exposure.

The implications of these findings are profound, suggesting that paraprobiotics like FK-23 can serve as functional food components to safeguard reproductive health in the modern chemical-laden environment. Given the global prevalence of BPA exposure and the escalating incidence of male infertility, dietary interventions leveraging microbiome-derived substances could represent a transformative, non-invasive approach to counter reproductive toxicity.

Moving forward, the research team stresses the necessity for comprehensive mechanistic studies to delineate precisely how gut microbiota-derived signals converge on the reproductive axis to exert protective effects. Furthermore, translating these promising preclinical results into human clinical trials will be critical to validate FK-23’s efficacy and safety as a preventative strategy against environmental reproductive toxicants.

This research emerges at a pivotal moment when the intersection of environmental health, microbiome science, and reproductive medicine offers unprecedented opportunities for intervention. The study not only illuminates the insidious harm inflicted by BPA but also exemplifies the innovative potential of paraprobiotics as dual-function agents—supporting gut health while mitigating systemic oxidative damage.

Moreover, the research highlights the importance of a holistic approach to chemical exposure mitigation. Instead of relying solely on regulatory bans and removal of harmful substances, integrating dietary bioactives capable of modulating host resilience represents an adaptive strategy to protect vulnerable populations from unavoidable environmental insults.

Professor Yukiko Minamiyama, leading the investigation at OMU’s Graduate School of Medicine, emphasizes the broader potential of lactic acid bacteria-derived components beyond reproductive health. Such bioactive compounds could be leveraged to combat oxidative stress-related conditions pervasive in aging and chronic diseases, further underscoring the health-promoting versatility of paraprobiotics.

In conclusion, the OMU study published in the Journal of Functional Foods marks a significant advancement in reproductive toxicology and microbiota research. FK-23’s ability to prevent BPA-induced sperm toxicity paves the way for novel nutritional interventions aimed at preserving male fertility in a chemically complex world. As research efforts continue, the integration of paraprobiotics into functional food formulations holds promise for enhancing reproductive longevity and fostering generational health.

Subject of Research: Animals

Article Title: Preventive effect of paraprobiotic Enterococcus faecalis FK-23 on bisphenol A-induced sperm toxicity

News Publication Date: 18-Feb-2026

References: Journal of Functional Foods, DOI: 10.1016/j.jff.2026.107205

Image Credits: Osaka Metropolitan University

Keywords: Bisphenol A, BPA, sperm toxicity, oxidative stress, reactive oxygen species, paraprobiotics, Enterococcus faecalis, FK-23, reproductive health, gut-immune axis, antioxidant therapy, male fertility

Cisplatin is a platinum-based chemotherapeutic widely utilized in the treatment of various malignancies, including testicular, bladder, and ovarian cancers. Despite its efficacy in combating rapidly dividing cancer cells, cisplatin’s mechanism is indiscriminately cytotoxic, resulting in collateral damage to non-cancerous tissues. The testes are particularly susceptible to such damage due to their high rate of cell division and sensitivity to oxidative insults. The production of reactive oxygen species (ROS), a byproduct of cisplatin treatment, leads to oxidative stress—a condition that overwhelms the endogenous antioxidant defenses and triggers lipid peroxidation, DNA damage, and apoptosis within testicular tissue.

To explore selenium’s protective capacity, the researchers designed an experimental study using a well-structured animal model. Thirty-eight male rats were methodically assigned into four distinct groups: a control cohort, a selenium-only group, a cisplatin-only group, and a group treated with both cisplatin and selenium. Selenium was administered to investigate its known antioxidant properties, specifically its role in scavenging ROS and bolstering the activity of antioxidant enzymes such as glutathione peroxidase and superoxide dismutase (SOD), which are crucial for maintaining redox homeostasis within cells.

Subsequent analyses focused on multiple biomarkers indicative of oxidative stress and reproductive health. These included the measurement of malondialdehyde (MDA) levels, a reliable marker for lipid peroxidation; SOD activity to assess antioxidant enzymatic function; total antioxidant status (TAS); and total oxidant status (TOS). Investigators also evaluated physiological parameters such as testicular weight and serum testosterone levels, providing a comprehensive overview of both structural and functional outcomes following treatment.

The data revealed that rats exposed solely to cisplatin experienced a substantial decline in testicular weight alongside a concomitant reduction in testosterone levels. These changes reflect significant testicular atrophy and impaired Leydig cell function, integral to hormone synthesis. Moreover, oxidative stress markers were markedly elevated in cisplatin-treated rats, confirming the drug’s pro-oxidant effects. Increased MDA and TOS levels alongside suppressed SOD and TAS values evidenced an imbalance skewed toward oxidative damage.

Conversely, administration of selenium in conjunction with cisplatin markedly mitigated these deleterious effects. The selenium-treated group showed improved antioxidant profiles with reduced lipid peroxidation and enhanced enzymatic defense. Importantly, testosterone levels were partially restored, and testicular weight reduction was less pronounced than in the cisplatin-only group. These findings strongly suggest that selenium supplementation confers cytoprotective effects within testicular tissue, potentially preserving reproductive capacity during chemotherapy.

In discussing the underlying mechanisms, the authors highlight selenium’s integral role in the biosynthesis of selenoproteins, many of which have antioxidant functions. By enhancing the activity of glutathione peroxidase and other selenoenzymes, selenium fortifies cellular defenses against ROS-induced damage. This enzymatic activity curtails oxidative stress, preserving cellular integrity and functionality within the testes. Hence, selenium’s antioxidant action directly counters the oxidative molecules precipitated by cisplatin, stabilizing the redox environment.

Dr. Gulsum Abusoglu, the study’s lead author, emphasized that “selenium supplementation reduced testicular damage and facilitated partial recovery of testosterone production compromised by cisplatin, hinting at its potential as a protective agent for male reproductive health during chemotherapy regimens.” This insight aligns with a growing body of literature advocating for antioxidant adjuncts to reduce chemotherapy-related systemic toxicities.

Co-author Dr. Melek Altunkaya underscores the clinical implications of these findings by noting that “oxidative stress is a central mediator driving chemotherapy-induced testicular dysfunction; thus, antioxidants like selenium may serve as viable candidates to preserve fertility and hormonal balance in male cancer patients.” The study’s translational relevance is especially pertinent given the increasing survivorship rates and the importance of quality-of-life considerations in oncologic care.

However, the researchers prudently caution that the experimental design was confined to a rodent model and involved a single selenium dosing regimen. Whether these results translate to human physiology remains uncertain, necessitating further clinical trials to evaluate optimal dosing, safety profiles, and long-term outcomes. This careful approach underscores the complexity of integrating micronutrient supplementation within standardized cancer therapies.

Beyond its specific focus on selenium and cisplatin, the study contributes to the broader understanding of oxidative stress’s impact on male fertility and the therapeutic potential of antioxidants. It invites deeper investigations into how targeted antioxidant therapies can alleviate side effects not only in the gonads but in other vulnerable organ systems affected by chemotherapy.

In conclusion, the research conducted at Selçuk University elucidates the protective effects of selenium against cisplatin-induced testicular toxicity, revealing a promising avenue toward preserving male reproductive health during cancer treatment. While the findings are preliminary and preclinical, they offer a vital foundation for future research aimed at integrating antioxidant strategies to mitigate the collateral damage of life-saving chemotherapeutic interventions.

Subject of Research: Effects of selenium on reproductive function and oxidative stress in male rats with cisplatin-induced testicular damage

Article Title: Effect of selenium on reproductive function and oxidative stress in male rats with cisplatin-induced testicular damage

News Publication Date: 1-Mar-2025

Web References:
DOI: 10.1097/RD9.0000000000000135

Image Credits: Gulsum Abusoglu, Melek Altunkaya, and Bahadir Ozturk

Keywords: Oxidative stress, cisplatin, selenium, antioxidants, testicular toxicity, male fertility, reactive oxygen species, chemotherapy side effects, malondialdehyde, superoxide dismutase, total antioxidant status, total oxidant status